3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34837846 | High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma. | 2022 Jan | 1 |
| 2 | 34539849 | Pan-RAF inhibitor LY3009120 is highly synergistic with low-dose cytarabine, but not azacitidine, in acute myeloid leukemia with RAS mutations. | 2021 Nov | 1 |
| 3 | 26343583 | Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers. | 2015 Sep 14 | 1 |